TickerFacts.

Company research / RFL

Rafael Holdings, Inc. (RFL)

Build a valuation ↗↓ Download CSV

CIK 0001713863 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jul 31

For the year ended 2025-07-31, Rafael Holdings, Inc. reported revenue of $917.0K. Revenue grew 44.0% from the prior annual period. Over the twelve months to 2026-04-30, revenue was $980.0K.

Key ratios (year ended 2025-07-31)

n/m
Operating margin
n/m
Net margin
-31.0%
Return on year-end equity
44.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-30

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-04-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-04-30		2025-07-312024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-31
Revenue$980.0K$917.0K$637.0K$279.0K$410.0K$802.0K$4.91M$4.93M$4.37M$5.62M$5.59M
Cost of Revenuen/an/a$154.0Kn/a$3.50M$3.17Mn/an/an/an/an/a
Gross Profit (computed)n/an/a$483.0Kn/a-$3.09M-$2.37Mn/an/an/an/an/a
R&D Expense$24.41M$12.82M$4.17M$6.31M$8.74M$4.91M$2.39M$1.03M$995.0Kn/an/a
Operating Income-$36.44M-$29.16M-$102.63M-$15.04M-$60.48M-$28.20M-$8.46M-$6.70M-$3.84M$221.0K$1.19M
Depreciation & Amortization$203.0K$288.0K$225.0K$78.0K$72.0K$70.0K$1.87M$1.78M$1.70M$1.67M$1.64M
EBITDA-$36.24M-$28.87M-$102.40M-$14.96M-$60.41M-$28.13M-$6.60M-$4.92M-$2.14M$1.89M$2.83M
Net Income-$32.55M-$30.52M-$34.41M-$1.88M-$124.66M-$23.06M-$10.75M-$4.69M-$11.65M$138.0K$710.0K
EPS (Diluted)n/a-$1.04-$1.45-$0.08-$6.31-$1.49n/an/a-$0.93$0.01$0.06
Total Assets$91.99M$114.11M$96.83M$98.83M$118.32M$154.06M$136.35M$142.14M$116.92M$86.20Mn/a
Total Liabilities$11.19M$15.74M$10.57M$2.20M$21.11M$17.35M$5.82M$17.38M$1.35M$24.13Mn/a
Shareholders' Equity$80.80M$98.37M$86.26M$96.63M$97.21M$136.70M$130.53M$124.76M$115.56M$62.08M$48.81M
Cash & Equivalents$30.50M$52.77M$2.67M$21.50M$26.54M$7.85M$6.21M$12.02M$15.80M$11.76M$2.34M
Operating Cash Flow-$31.99M-$18.92M-$7.80M-$10.89M-$26.08M-$15.60M-$4.67M-$3.13M-$1.81M-$1.62M$72.0K
Capital Expenditures$4.0K$4.0K$143.0Kn/a$2.0K$206.0K$534.0K$399.0K$710.0K$1.82M$1.55M
Free Cash Flow-$31.99M-$18.93M-$7.95Mn/a-$26.08M-$15.81M-$5.20M-$3.53M-$2.52M-$3.44M-$1.48M
Weighted Average Diluted Sharesn/a29.42M23.75M23.26M19.77M16.52Mn/an/an/a12.5K12.5K
EPS (Basic)n/a-$1.04-$1.45-$0.08-$6.31-$1.49n/an/a-$0.93$0.01$0.06

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView